152 related articles for article (PubMed ID: 28244953)
1. Effect of Clopidogrel on Thrombus Formation in an Ex Vivo Parallel Plate Flow Chamber Model Cannot Be Reversed by Addition of Platelet Concentrates or vWF Concentrate.
Jahn K; Suchodolski K; Schäfer A; Sahlmann B; Küster U; Echtermeyer F; Calmer S; Theilmeier G; Johanning K
Anesth Analg; 2017 Apr; 124(4):1091-1098. PubMed ID: 28244953
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model.
Wåhlander K; Eriksson-Lepkowska M; Nyström P; Eriksson UG; Sarich TC; Badimon JJ; Kalies I; Elg M; Bylock A
Thromb Haemost; 2006 Mar; 95(3):447-53. PubMed ID: 16525572
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system.
Ågren A; Holmström M; Schmidt DE; Hosokawa K; Blombäck M; Hjemdahl P
Thromb Haemost; 2017 Jan; 117(1):75-85. PubMed ID: 27761577
[TBL] [Abstract][Full Text] [Related]
4. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans.
Cadroy Y; Bossavy JP; Thalamas C; Sagnard L; Sakariassen K; Boneu B
Circulation; 2000 Jun; 101(24):2823-8. PubMed ID: 10859288
[TBL] [Abstract][Full Text] [Related]
5. Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation.
Goto S; Tamura N; Sakakibara M; Ikeda Y; Handa S
Platelets; 2001 Nov; 12(7):406-14. PubMed ID: 11674857
[TBL] [Abstract][Full Text] [Related]
6. A double-blind randomized comparison of combined aspirin and ticlopidine therapy versus aspirin or ticlopidine alone on experimental arterial thrombogenesis in humans.
Bossavy JP; Thalamas C; Sagnard L; Barret A; Sakariassen K; Boneu B; Cadroy Y
Blood; 1998 Sep; 92(5):1518-25. PubMed ID: 9716578
[TBL] [Abstract][Full Text] [Related]
7. Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation.
Badimon L; Badimon JJ; Turitto VT; Vallabhajosula S; Fuster V
Circulation; 1988 Dec; 78(6):1431-42. PubMed ID: 3263902
[TBL] [Abstract][Full Text] [Related]
8. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
Vilahur G; Segalés E; Salas E; Badimon L
Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
[TBL] [Abstract][Full Text] [Related]
9. [Non ST elevation acute coronary syndrome. Some characteristics of coagulation and von Willebrand factor during short term use of ticlopidine or clopidogrel].
Averkov OV; Slavina NN; Gratsianskiĭ NA
Kardiologiia; 2003; 43(10):50-9. PubMed ID: 14593356
[TBL] [Abstract][Full Text] [Related]
10. Shear-dependent functions of the interaction between soluble von Willebrand factor and platelet glycoprotein Ib in mural thrombus formation on a collagen surface.
Sugimoto M; Tsuji S; Kuwahara M; Matsui H; Miyata S; Fujimura Y; Yoshioka A
Int J Hematol; 1999 Jan; 69(1):48-53. PubMed ID: 10641443
[TBL] [Abstract][Full Text] [Related]
11. Measurement of residual platelet thrombogenicity under arterial shear conditions in cerebrovascular disease patients receiving antiplatelet therapy.
Yamazaki M; Ohnishi T; Hosokawa K; Yamaguchi K; Yoneyama T; Kawashima A; Okada Y; Kitagawa K; Uchiyama S
J Thromb Haemost; 2016 Sep; 14(9):1788-97. PubMed ID: 27328457
[TBL] [Abstract][Full Text] [Related]
12. Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.
Karnicki K; Leadley RJ; Baxi S; Peterson T; Wysokinski W; McBane RD
Thromb Haemost; 2008 Apr; 99(4):759-66. PubMed ID: 18392334
[TBL] [Abstract][Full Text] [Related]
13. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.
Hosokawa K; Ohnishi T; Sameshima H; Miura N; Ito T; Koide T; Maruyama I
Thromb Haemost; 2013 Jan; 109(1):102-11. PubMed ID: 23179055
[TBL] [Abstract][Full Text] [Related]
14. Mathematical analysis of mural thrombogenesis. Concentration profiles of platelet-activating agents and effects of viscous shear flow.
Folie BJ; McIntire LV
Biophys J; 1989 Dec; 56(6):1121-41. PubMed ID: 2611327
[TBL] [Abstract][Full Text] [Related]
15. Role of plasma and platelet von Willebrand factor in arterial thrombogenesis and hemostasis in the pig.
André P; Brouland JP; Roussi J; Bonneau M; Pignaud G; Bal dit Sollier C; Hainaud P; Vaiman M; Drouet L
Exp Hematol; 1998 Jul; 26(7):620-6. PubMed ID: 9657137
[TBL] [Abstract][Full Text] [Related]
16. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
[TBL] [Abstract][Full Text] [Related]
17. Reduced thrombus cohesion in an ex vivo human model of arterial thrombosis induced by clopidogrel treatment: kinetics of the effect and influence of single and double loading-dose regimens.
Bal dit Sollier C; Mahé I; Berge N; Simoneau G; Bergmann JF; Drouet L
Thromb Res; 2003; 111(1-2):19-27. PubMed ID: 14644074
[TBL] [Abstract][Full Text] [Related]
18. Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers.
Cadroy Y; Thalamas C; Sakariassen K; Boneu B
Thromb Res; 2005; 116(4):293-300. PubMed ID: 16038713
[TBL] [Abstract][Full Text] [Related]
19. Anti-human VWF monoclonal antibody SZ-123 prevents arterial thrombus formation by inhibiting VWF-collagen and VWF-platelet interactions in Rhesus monkeys.
Zhao YM; Jiang M; Ji SD; He Y; Shen F; Li XM; Ruan CG
Biochem Pharmacol; 2013 Apr; 85(7):945-53. PubMed ID: 23295157
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the von Willebrand (VWF)-collagen interaction by an antihuman VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons.
Wu D; Vanhoorelbeke K; Cauwenberghs N; Meiring M; Depraetere H; Kotze HF; Deckmyn H
Blood; 2002 May; 99(10):3623-8. PubMed ID: 11986216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
